Filter
1881
Text search:
drug
trial
Featured
Recommendations
184
New Publications
323
Language
Document type
No document type
1055
Guidelines
322
Studies & Reports
315
Manuals
82
Fact sheets
35
Strategic & Response Plan
30
Training Material
17
Situation Updates
9
Infographics
5
Resource Platforms
4
Brochures
3
App
1
Countries / Regions
India
95
Global
71
South Africa
56
Western and Central Europe
41
Kenya
29
Africa
29
Uganda
27
Ethiopia
25
Eastern Europe
23
Russia
23
Tanzania
22
Nigeria
21
Zambia
21
Liberia
20
Ukraine
19
Sierra Leone
17
Zimbabwe
17
Latin America and the Carribbean
17
Ghana
15
Nepal
15
Malawi
15
Philippines
14
Bangladesh
13
Brazil
13
Rwanda
12
Myanmar / Burma
11
Colombia
9
South–East Asia Region
9
South Sudan
8
Cambodia
8
Mozambique
8
Namibia
8
East and Southern Africa
8
Asia
8
Germany
7
Indonesia
7
Lesotho
7
West and Central Africa
7
Congo, Democratic Republic of
6
USA
6
Thailand
6
Middle East and North Africa
5
Tajikistan
5
Guinea
4
Argentina
4
Eswatini/ Swaziland
4
Vietnam
4
Senegal
3
Cameroon
3
Syria
3
Sudan
3
Angola
3
Yemen
3
Paraguay
3
Venezuela
3
Laos
3
Georgia
3
Burkina Faso
2
Guinea-Bissau
2
Haiti
2
China
2
North Macedonia
2
Hungary
2
Botswana
2
Bolivia
2
Mexico
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Poland
2
Kyrgyzstan
2
Jamaica
2
Spain
2
Belarus
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Somalia
1
Pakistan
1
Jordan
1
Lebanon
1
Gambia
1
Singapore
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Peru
1
Ecuador
1
Bhutan
1
Armenia
1
Southern Africa
1
Timor Leste/ East Timor
1
Qatar
1
Lithuania
1
Iran
1
Kazakhstan
1
North America
1
Belgium
1
France
1
United Kingdom
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
466
Clinical Guidelines
248
Public Health
92
Women & Child Health
81
Key Resources
26
Pharmacy & Technologies
18
Capacity Building
11
Toolboxes
HIV
302
Mental Health
273
TB
221
COVID-19
127
NTDs
119
NCDs
62
Ebola & Marburg
44
AMR
42
Pharmacy
40
Malaria
39
Caregiver
21
Disability
18
Refugee
18
Planetary Health
15
Rapid Response
12
Health Financing Toolbox
12
Global Health Education
9
Cholera
6
Polio
6
2.0 Rapid Response
6
Conflict
5
Natural Hazards
4
Zika
4
Specific Hazards
3
Social Ethics
3
Key populations brief.
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie
...
Informe sobre poblaciones clave.
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es
...
The END TB Strategy
Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных наркотиков
Infection Control Assessment Tool
recommended
Strengthening Parmaceutical Systems. 2nd edition
National Tuberculosis Programme and Senior Paediatricians
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T ...
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T ...
Legislative and Policy analysis and recommendations for reform
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...